|
⚲
|
| Keyboard |
| Oberland Capital Management LLC
✚
|
|
|---|---|
| CRD # | 169109 |
| SEC # | 801-87179 |
| CIK # | |
| AUM | 3,219.5 M (2026-05-01) |
| Employees | 23 (61% Investors, 0% Brokers) |
| Phone | 212-257-5850 |
| Address | 1700 Broadway New York, NY 10019 |
| Source | [IAPD] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Oberland Capital Healthcare Solutions Co-Invest Master Fund II LP | [2026-03-31] | 152.3 M | |
| Filed 2025-11-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Oberland Capital Healthcare Solutions Master Fund II LP | [2026-03-31] | 181.0 M | |
| Filed 2025-11-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | Quantbio Absolute Return Fund LP | [2025-03-31] | 36.3 M | 32.7 M |
| Filed 2026-02-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Oberland Capital Healthcare III Brazos Co-Invest LP | 2023-03-31 | 55.5 M | |
| PE | Oberland Capital Healthcare Master Fund III LP | [2023-03-31] | 1,220.1 M | |
| Filed 2022-07-05 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Oberland Orion Co-Invest Fund LP | 2023-03-31 | 179.9 M | |
| HF | Quantbio Innovations Fund LP | [2023-03-31] | 4.4 M | 11.1 M |
| Filed 2025-05-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Oberland Capital Healthcare Solutions Co-Invest Master Fund LP | [2020-03-30] | 386.2 M | |
| Filed 2019-12-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Oberland Capital Healthcare Solutions Master Fund LP | [2020-03-30] | 617.8 M | |
| Filed 2019-12-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Oberland Capital Healthcare Master Fund II LP | [2018-03-30] | 324.6 M | |
| Filed 2017-12-12 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Oberland Capital Healthcare Master Fund LP | [2013-09-13] | 251.3 M | 41.5 M |
| Offered $350,000,000 · Filed 2014-09-29 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $98,665,000 · Duration More than one year · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 25 | 3.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 1 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 26 | 3.2 |
| By Discretionary | ||
| Discretionary | 26 | 3.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 26 | 3.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.5 | |
| United States Persons | 1.7 | |
| Total | 26 | 3.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Andrew Rubinstein | Executive Officer | 17 | 2 | |
| Jean-Pierre Naegeli | Executive Officer | 16 | 2 |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Hill Path Capital LP
✚
|
NY | 3,408.2 M |
|
York Capital Management Global Advisors LLC
✚
|
NY | 3,264.5 M |
|
Foresite Capital Management LLC
✚
|
CA | 3,237.0 M |
|
KA Fund Advisors LLC
✚
|
TX | 3,188.0 M |
|
Burford Capital Investment Management LLC
✚
|
IL | 3,172.2 M |
|
Tennenbaum Capital Partners LLC
✚
|
CA | 3,156.6 M |
|
Anthelion Capital Partners LLC
✚
|
NY | 3,153.9 M |
|
Greywolf Capital Management LP
✚
|
NY | 3,084.9 M |
|
Pan Capital Management LP
✚
|
TX | 3,078.9 M |
|
Z Capital Group LLC
✚
|
NY | 3,054.9 M |